Related Experiment Video
Updated: Jun 5, 2025

12:11
Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization
Published on: February 27, 2020
6.8K
Molecular Targeted Engagement of DPP9 in Rat Tissue Using CETSA, SP3 Processing, and Absolute Quantitation Mass
Matthew T Mazur1, Baojen Shyong1, Qian Huang2
1PDMB Data Science, Automation & Translational Analytics, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania 19478, United States.
ACS Chemical Biology
|December 6, 2024
Summary
The cellular thermal shift assay (CETSA) quantifies drug target engagement. This study successfully applied CETSA with mass spectrometry to measure dipeptidyl peptidase 9 (DPP9) engagement in rat tissues, aiding drug discovery.
Area of Science:
- Biochemistry
- Pharmacology
- Analytical Chemistry
Background:
- Cellular thermal shift assay (CETSA) is crucial for assessing small molecule ligand binding to protein targets.
- Improving quantitation and specificity in CETSA is vital for accurate target engagement studies.
- Mass spectrometry offers enhanced analytical capabilities for precise quantification in biological assays.
Purpose of the Study:
- To evaluate target engagement of dipeptidyl peptidase 9 (DPP9) in rat tissue using CETSA.
- To implement advanced analytical methods for absolute quantitation of DPP9 engagement.
- To demonstrate the utility of CETSA coupled with mass spectrometry for in vivo drug discovery.
Main Methods:
- Cellular thermal shift assay (CETSA) was performed on rat tissue samples.
- Single-pot, solid-phase-enhanced sample preparation (SP3) was utilized for sample processing.
- High-resolution mass spectrometry was employed for absolute quantitation of DPP9.
Main Results:
- CETSA demonstrated a temperature-dependent melting curve for DPP9 upon ex vivo compound incubation.
- In vivo studies showed dose-dependent engagement of DPP9 in response to treatment.
- Absolute quantitation by mass spectrometry enabled precise measurement of DPP9 engagement in dosed animals.
Conclusions:
- The study successfully extended CETSA to in vivo dosed-animal samples.
- Absolute quantitation of DPP9 by mass spectrometry provides a robust method for target engagement assessment.
- This integrated approach offers a viable strategy for interrogating therapeutic molecules in drug discovery.

